Beyond Air Inc (XAIR)

Healthcare | Medical Devices
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 1,760,000 1,072,000 798,000 683,000
Cost of Revenue 1,604,000 1,287,000 1,882,000 1,016,000
Gross Profit 156,000 -215,000 -1,084,000 -333,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 4,687,000 7,732,000 7,163,000 7,239,000
Operating Expenses 7,773,000 10,737,000 11,749,000 13,248,000
Operating Income -7,617,000 -10,952,000 -12,833,000 -13,580,000
Interest Expense 548,000 549,000 927,000 964,000
Income Before Tax -8,077,999 -13,333,000 -14,029,000 -13,055,000
Income Tax Expense -387,000 0 -671,000 0
Net Income -7,691,000 -13,032,000 -13,358,000 -12,201,000
Per Share
EPS -1.53 -0.15 -0.14 -0.14
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 3,705,000 1,159,000 0 0 873,190
Cost of Revenue 5,368,000 2,466,000 555,000 588,000 0
Gross Profit -1,663,000 -1,307,000 -555,000 -588,000 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 26,017,000 37,337,000 34,694,000 18,408,000 10,468,341
Operating Expenses 42,874,000 61,700,000 51,504,000 30,210,000 23,086,690
Operating Income -44,537,000 -63,006,000 -51,504,000 -40,710,000 -22,213,500
Interest Expense 3,019,000 2,912,000 30,000 775,000 641,626
Income Before Tax -48,479,000 -64,295,000 -59,401,000 -44,060,000 -22,874,731
Income Tax Expense 0 0 -3,555,000 -108,000 0
Net Income -46,625,000 -60,242,000 -55,816,000 -43,177,000 -22,874,731
Per Share
EPS -13.77 -0.91 -0.93 -1.68 -1.27
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 4,665,000 11,378,000 29,158,000 80,242,000
Short Term Investments 2,252,000 23,090,000 16,724,000 0
Net Receivables 860,000 548,000 651,000 604,000
Inventory 2,417,000 2,127,000 1,129,000 350,000
Total Current Assets 16,018,000 43,936,000 59,410,000 92,945,000
Property Plant Equipment 12,719,000 11,485,000 7,496,000 4,210,000
Goodwill and Intangibles 1,222,000 1,427,000 1,632,000 1,837,000
Total Assets 30,062,000 56,961,000 68,749,000 99,199,000
Liabilities
Account Payables 1,950,000 1,948,000 2,016,000 1,129,000
Short Term Debt 1,005,000 1,218,000 1,151,000 1,208,000
Total Current Liabilities 5,000,000 11,567,000 19,780,000 10,712,000
Long Term Debt 10,683,000 16,619,000 2,441,000 2,279,000
Total Liabilities 15,721,000 29,775,000 26,721,000 20,990,000
Shareholders Equity
Retained Earnings -286,322,000 -239,697,000 -179,455,000 -123,639,000
Total Shareholders Equity 13,583,000 25,048,000 37,915,000 72,704,000
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 4,665,000 11,378,000 29,158,000 80,242,000 34,630,682
Short Term Investments 2,252,000 23,090,000 16,724,000 0 0
Net Receivables 860,000 548,000 651,000 604,000 466,272
Inventory 2,417,000 2,127,000 1,129,000 350,000 0
Total Current Assets 16,018,000 43,936,000 59,410,000 92,945,000 37,222,803
Property Plant Equipment 12,719,000 11,485,000 7,496,000 4,210,000 2,789,727
Goodwill and Intangibles 1,222,000 1,427,000 1,632,000 1,837,000 374,686
Total Assets 30,062,000 56,961,000 68,749,000 99,199,000 40,525,096
Liabilities
Account Payables 1,950,000 1,948,000 2,016,000 1,129,000 1,324,988
Short Term Debt 1,005,000 1,218,000 1,151,000 1,208,000 669,655
Total Current Liabilities 5,000,000 11,567,000 19,780,000 10,712,000 3,799,581
Long Term Debt 10,683,000 16,619,000 2,441,000 2,279,000 6,261,662
Total Liabilities 15,721,000 29,775,000 26,721,000 20,990,000 10,061,243
Shareholders Equity
Retained Earnings -286,322,000 -239,697,000 -179,455,000 -123,639,000 -80,461,807
Total Shareholders Equity 13,583,000 25,048,000 37,915,000 72,704,000 30,463,853
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income -48,479,000 -60,242,000 -59,401,000 -44,060,000
Depreciation & Amortization 3,571,000 2,352,000 1,170,000 588,000
Stock Based Compensation 9,146,000 21,337,000 19,558,000 7,831,000
Change in Working Capital -6,152,000 -16,038,000 5,393,000 11,834,000
Operating Cash Flow -38,218,000 -56,014,000 -33,009,000 -23,134,000
Investing Activities
Capital Expenditure -5,883,000 -5,745,000 -3,877,000 -1,449,000
Investments -5,883,000 -5,745,000 -3,877,000 -1,449,000
Investing Cash Flow 14,905,000 -12,235,000 -20,587,000 -1,450,000
Financing Activities
Debt Repayment -6,728,000 14,983,000 -1,009,000 -658,000
Common Stock Issued/Repurchased 23,009,000 27,967,000 3,705,000 72,827,000
Dividends Paid 0 0 0 0
Financing Cash Flow 16,646,000 43,167,000 2,696,000 79,450,000
Summary
Free Cash Flow -44,101,000 -61,759,000 -36,886,000 -24,583,000
Net Change in Cash -6,712,000 -25,160,000 -50,943,000 54,962,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income -48,479,000 -60,242,000 -59,401,000 -44,060,000 -22,874,731
Depreciation & Amortization 3,571,000 2,352,000 1,170,000 588,000 210,979
Stock Based Compensation 9,146,000 21,337,000 19,558,000 7,831,000 4,894,918
Change in Working Capital -6,152,000 -16,038,000 5,393,000 11,834,000 -2,076,706
Operating Cash Flow -38,218,000 -56,014,000 -33,009,000 -23,134,000 -19,639,376
Investing Activities
Capital Expenditure -5,883,000 -5,745,000 -3,877,000 -1,449,000 -890,407
Investments -5,883,000 -5,745,000 -3,877,000 -1,449,000 -890,407
Investing Cash Flow 14,905,000 -12,235,000 -20,587,000 -1,450,000 -890,407
Financing Activities
Debt Repayment -6,728,000 14,983,000 -1,009,000 -658,000 -404,094
Common Stock Issued/Repurchased 23,009,000 27,967,000 3,705,000 72,827,000 30,111,223
Dividends Paid 0 0 0 0 0
Financing Cash Flow 16,646,000 43,167,000 2,696,000 79,450,000 30,332,379
Summary
Free Cash Flow -44,101,000 -61,759,000 -36,886,000 -24,583,000 -20,529,783
Net Change in Cash -6,712,000 -25,160,000 -50,943,000 54,962,000 9,802,596